首页|期刊导航|BIOCELL|ARPC1A Promotes NSCLC Malignancy via Stimulating the Drug Resistance and Cell Migration

ARPC1A Promotes NSCLC Malignancy via Stimulating the Drug Resistance and Cell Migration

Hongjuan Guo Dan Liu Ruyu Yan Tianjing Zhang Kecheng Zhou Minxia Liu

BIOCELL2025，Vol.49Issue(3)：P.483-502,20.

BIOCELL2025，Vol.49Issue(3)：P.483-502,20.DOI:10.32604/biocell.2025.062143

ARPC1A Promotes NSCLC Malignancy via Stimulating the Drug Resistance and Cell Migration

Hongjuan Guo ¹Dan Liu ²Ruyu Yan ²Tianjing Zhang ³Kecheng Zhou ²Minxia Liu¹

作者信息

1. School of Life Sciences,Anhui Medical University,Hefei,230032,China
2. School of Life Sciences,Anhui Medical University,Hefei,230032,China Department of Biochemistry and Molecular Biology,School of Basic Medical Sciences,Anhui Medical University,Hefei,230032,China
3. Department of Orthopaedics,Hejin Shengji Hospital,Yuncheng,043300,China
折叠

摘要

关键词

NSCLC/ARPC1A/drug resistance/EMT/immune infiltration dynamics

分类

医药卫生

引用本文复制引用

Hongjuan Guo,Dan Liu,Ruyu Yan,Tianjing Zhang,Kecheng Zhou,Minxia Liu..ARPC1A Promotes NSCLC Malignancy via Stimulating the Drug Resistance and Cell Migration[J].BIOCELL,2025,49(3):P.483-502,20.

基金项目

supported by the Natural Science Foundation of Anhui Province(ML 2308085MC80) （ML 2308085MC80）

the Anhui Medical University Research and Innovation Talent Team(KZ). （KZ）

BIOCELL

ISSN：0327-9545

访问量0

下载量0

段落导航